Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Non-Current Assets of $683.1 million in Q1 2026, down 2.27% quarter-over-quarter from $699.0 million in Q4 2025, and up 0.56% on a YoY basis from $679.4 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Non-Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Non-Current Assets history runs 7 years deep, the most recent figure standing at $683.1 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 0.56% year-over-year to $683.1 million; the TTM figure through Mar 2026 stood at $2.8 billion (up 0.94% YoY), while the FY2025 annual figure was $699.0 million, up 4.16% from the prior year.
- Non-Current Assets was $683.1 million for Q1 2026 at Ascend Wellness Holdings, down from $699.0 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $699.0 million in Q4 2025 to a low of $453.7 million in Q1 2022.
- Historically, Non-Current Assets has averaged $660.6 million across 5 years, with a median of $682.3 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets surged 189.73% in 2022, then decreased 2.84% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $673.4 million in 2022, then gained by 2.56% to $690.7 million in 2023, then slipped by 2.84% to $671.1 million in 2024, then increased by 4.16% to $699.0 million in 2025, then slipped by 2.27% to $683.1 million in 2026.
- The last three Non-Current Assets figures came in at $683.1 million (Q1 2026), $699.0 million (Q4 2025), and $691.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 683.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 683.13 Mn |
| Dec 31, 2025 | 698.98 Mn |
| Sep 30, 2025 | 691.15 Mn |
| Jun 30, 2025 | 678.21 Mn |
| Mar 31, 2025 | 679.36 Mn |
| Dec 31, 2024 | 671.06 Mn |
| Sep 30, 2024 | 682.30 Mn |
| Jun 30, 2024 | 693.10 Mn |
| Mar 31, 2024 | 689.82 Mn |
| Dec 31, 2023 | 690.69 Mn |
| Sep 30, 2023 | 696.66 Mn |
| Jun 30, 2023 | 686.42 Mn |
| Mar 31, 2023 | 665.88 Mn |
| Dec 31, 2022 | 673.42 Mn |
| Sep 30, 2022 | 628.12 Mn |
| Jun 30, 2022 | 568.84 Mn |
| Mar 31, 2022 | 453.65 Mn |
| Dec 31, 2021 | 465.42 Mn |
| Sep 30, 2021 | 417.22 Mn |
| Jun 30, 2021 | 389.37 Mn |